Market Cap 461.45M
Revenue (ttm) 0.00
Net Income (ttm) -167.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,691,900
Avg Vol 4,975,412
Day's Range N/A - N/A
Shares Out 163.06M
Stochastic %K 25%
Beta 3.26
Analysts Strong Sell
Price Target $13.38

Company Profile

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. The company's lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, systemic lupus erythe...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 759 3100
Address:
2929 Arch Street, Suite 600, Philadelphia, United States
JuggernautRaider
JuggernautRaider Jul. 21 at 10:35 AM
$CABA why not 💯
0 · Reply
Moonman321
Moonman321 Jul. 21 at 3:53 AM
$CABA this baby is ready for a 10% plus move
0 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jul. 20 at 7:56 PM
1 · Reply
JuggernautRaider
JuggernautRaider Jul. 19 at 8:50 PM
$CABA buying more, Shawn Tomasello is rarely wrong 😑
1 · Reply
Austinhilton
Austinhilton Jul. 19 at 4:09 PM
$SPCX $CABA $MA $TSLA $IMX.X This is exactly what I told you would happen. SpaceX is now following the path I warned you about: $225$175$123 Next stop: → $100 Tesla 2010 is repeating. Reminder: I’ve called every major market top and bottom for the last 15 years, including the tops in Gold and Silver, the collapse in Oil, the SpaceX drop, and Bitcoin’s crash. When I exit the markets completely, I’ll post it here publicly like I always do. Turn notifications on. If you’re not following yet, you’ll understand why that was a mistake later.
0 · Reply
BloomBoom
BloomBoom Jul. 19 at 5:05 AM
1 · Reply
Achandler787
Achandler787 Jul. 18 at 8:36 PM
$CABA so to be clear $LLY has recently invested in $CABA and their Chief Science officer is personally advising the business: plus Lily is printing cash and wants to buy (And has bought recently) immunology companies for Billions! CABA is a penny stock with potentially a home run immune disease 🦠 curative platform. All momentum stocks had a 27 year record sell off last week: not financial advice : BUY LOW ——😝
1 · Reply
Higherself
Higherself Jul. 18 at 1:38 PM
$CABA So if a hanle is formed at roughly the $3 mark to finish the little cup then the run up to form the 2nd side of the big cup...some quick hypothetical math gets me to $4.40 from 1st cup $9.65 on tbe 2nd...again completely hypothetical as we can 't see handles yet. Or am I looking at what your seeing starting wrong?
1 · Reply
Higherself
Higherself Jul. 18 at 1:28 PM
$CABA Is this a possible double cup? It says a double cup forms if a stock falls to a suppor level & makes a small (W) shaped recovery before completing the large cup! Am i seeing things or is this exactly what's happening?
0 · Reply
WastedTrader
WastedTrader Jul. 18 at 4:28 AM
$CABA this is going to/forming a new massive cup, if you were here in the 1's you know what im talking about 🚀😎
0 · Reply
Latest News on CABA
Cabaletta Bio Slides: Corporate presentation

Jun 3, 2026, 7:00 AM EDT - 6 weeks ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio Proxy statement: Proxy filing

Jun 1, 2026, 8:00 AM EDT - 7 weeks ago

Cabaletta Bio Proxy statement: Proxy filing


Cabaletta Bio presents new clinical data for rese-cel

2026-05-14T14:21:15.000Z - 2 months ago

Cabaletta Bio presents new clinical data for rese-cel


Cabaletta Bio reports Q1 EPS (39c), consensus (39c)

2026-05-14T12:08:57.000Z - 2 months ago

Cabaletta Bio reports Q1 EPS (39c), consensus (39c)


Cabaletta Bio Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 2 months ago

Cabaletta Bio Quarterly report: Q1 2026


Cabaletta Bio Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 2 months ago

Cabaletta Bio Earnings release: Q1 2026


Cabaletta Bio Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 2 months ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio, Cellares enter 10-year commercial agreement

2026-04-28T12:38:26.000Z - 2 months ago

Cabaletta Bio, Cellares enter 10-year commercial agreement


Cabaletta Bio Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Cabaletta Bio Proxy statement: Proxy filing


Cabaletta Bio Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Cabaletta Bio Proxy statement: Proxy filing


Cabaletta Bio Slides: Corporate presentation

Apr 20, 2026, 7:00 AM EDT - 3 months ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 3 months ago

Cabaletta Bio Proxy statement: Proxy filing


Cabaletta Bio price target raised to $16 from $15 at Guggenheim

2026-03-23T18:00:24.000Z - 4 months ago

Cabaletta Bio price target raised to $16 from $15 at Guggenheim


Cabaletta Bio reports Q4 EPS (40c), consensus (47c)

2026-03-23T11:40:46.000Z - 4 months ago

Cabaletta Bio reports Q4 EPS (40c), consensus (47c)


Cabaletta Bio Annual report: Q4 2025

Mar 23, 2026, 7:30 AM EDT - 4 months ago

Cabaletta Bio Annual report: Q4 2025


Cabaletta Bio Earnings release: Q4 2025

Mar 23, 2026, 7:30 AM EDT - 4 months ago

Cabaletta Bio Earnings release: Q4 2025


Cabaletta Bio Slides: Corporate presentation

Mar 23, 2026, 7:00 AM EDT - 4 months ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio announces 2026 strategic priorities

2026-01-12T13:38:11.000Z - 6 months ago

Cabaletta Bio announces 2026 strategic priorities


Cabaletta Bio Announces 2026 Strategic Priorities

Jan 12, 2026, 8:00 AM EST - 6 months ago

Cabaletta Bio Announces 2026 Strategic Priorities


Cabaletta Bio Slides: Corporate presentation

Jan 11, 2026, 7:00 AM EST - 6 months ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio Slides: Corporate Presentation

Dec 5, 2025, 7:00 AM EST - 8 months ago

Cabaletta Bio Slides: Corporate Presentation


Cabaletta Bio reports Q3 EPS (44c), consensus (46c)

2025-11-10T12:38:12.000Z - 9 months ago

Cabaletta Bio reports Q3 EPS (44c), consensus (46c)


Cabaletta Bio sees cash runway into 2H26

2025-11-10T12:37:22.000Z - 9 months ago

Cabaletta Bio sees cash runway into 2H26


Cabaletta Bio Quarterly report: Q3 2025

Nov 10, 2025, 7:30 AM EST - 9 months ago

Cabaletta Bio Quarterly report: Q3 2025


Cabaletta Bio Earnings release: Q3 2025

Nov 10, 2025, 7:30 AM EST - 9 months ago

Cabaletta Bio Earnings release: Q3 2025


Cabaletta Bio Registration statement: Registration Filing

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Cabaletta Bio Registration statement: Registration Filing


Cabaletta Bio Quarterly report: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 1 year ago

Cabaletta Bio Quarterly report: Q2 2025


Cabaletta Bio Earnings release: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 1 year ago

Cabaletta Bio Earnings release: Q2 2025


Cabaletta Bio Slides: Investor Presentation

Jun 11, 2025, 7:00 AM EDT - 1 year ago

Cabaletta Bio Slides: Investor Presentation


Cabaletta Bio Quarterly report: Q1 2025

May 15, 2025, 9:30 AM EDT - 1 year ago

Cabaletta Bio Quarterly report: Q1 2025


Cabaletta Bio Proxy statement: Proxy Filing

May 13, 2025, 8:00 AM EDT - 1 year ago

Cabaletta Bio Proxy statement: Proxy Filing


Cabaletta Bio Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Cabaletta Bio Proxy statement: Proxy Filing


Cabaletta Bio Earnings release: Q4 2024

Mar 31, 2025, 7:00 AM EDT - 1 year ago

Cabaletta Bio Earnings release: Q4 2024


Cabaletta Bio Annual report: Q4 2024

Mar 31, 2025, 7:00 AM EDT - 1 year ago

Cabaletta Bio Annual report: Q4 2024


Cabaletta Bio Transcript: Status Update

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cabaletta Bio Transcript: Status Update


Cabaletta Bio Press release: Status Update

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cabaletta Bio Press release: Status Update


Cabaletta Bio Slides: Status Update

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cabaletta Bio Slides: Status Update


Cabaletta Bio Quarterly report: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Cabaletta Bio Quarterly report: Q3 2024


Cabaletta Bio Earnings release: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Cabaletta Bio Earnings release: Q3 2024


Cabaletta Bio Quarterly report: Q2 2024

Aug 8, 2024, 7:15 AM EDT - 2 years ago

Cabaletta Bio Quarterly report: Q2 2024


Cabaletta Bio Earnings release: Q2 2024

Aug 8, 2024, 7:15 AM EDT - 2 years ago

Cabaletta Bio Earnings release: Q2 2024


Cabaletta Bio Transcript: Study Update

Jun 14, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Transcript: Study Update


Cabaletta Bio Press release: Study Update

Jun 14, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Press release: Study Update


Cabaletta Bio Slides: Study Update

Jun 14, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Slides: Study Update


Cabaletta Bio Quarterly report: Q1 2024

May 15, 2024, 7:00 AM EDT - 2 years ago

Cabaletta Bio Quarterly report: Q1 2024


Cabaletta Bio Earnings release: Q1 2024

May 15, 2024, 7:00 AM EDT - 2 years ago

Cabaletta Bio Earnings release: Q1 2024


Cabaletta Bio Slides: Corporate Presentation

May 15, 2024, 7:00 AM EDT - 2 years ago

Cabaletta Bio Slides: Corporate Presentation


Cabaletta Bio Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Proxy statement: Proxy Filing


Cabaletta Bio Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Proxy statement: Proxy Filing


Cabaletta Bio Earnings release: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Earnings release: Q4 2023


Cabaletta Bio Annual report: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Annual report: Q4 2023


Cabaletta Bio Slides: FY 2024

Jan 9, 2024, 8:15 PM EST - 2 years ago

Cabaletta Bio Slides: FY 2024


Cabaletta Bio Quarterly report: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

Cabaletta Bio Quarterly report: Q3 2023


Cabaletta Bio Earnings release: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

Cabaletta Bio Earnings release: Q3 2023


Cabaletta Bio Quarterly report: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

Cabaletta Bio Quarterly report: Q2 2023


Cabaletta Bio Earnings release: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

Cabaletta Bio Earnings release: Q2 2023


JuggernautRaider
JuggernautRaider Jul. 21 at 10:35 AM
$CABA why not 💯
0 · Reply
Moonman321
Moonman321 Jul. 21 at 3:53 AM
$CABA this baby is ready for a 10% plus move
0 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jul. 20 at 7:56 PM
1 · Reply
JuggernautRaider
JuggernautRaider Jul. 19 at 8:50 PM
$CABA buying more, Shawn Tomasello is rarely wrong 😑
1 · Reply
Austinhilton
Austinhilton Jul. 19 at 4:09 PM
$SPCX $CABA $MA $TSLA $IMX.X This is exactly what I told you would happen. SpaceX is now following the path I warned you about: $225$175$123 Next stop: → $100 Tesla 2010 is repeating. Reminder: I’ve called every major market top and bottom for the last 15 years, including the tops in Gold and Silver, the collapse in Oil, the SpaceX drop, and Bitcoin’s crash. When I exit the markets completely, I’ll post it here publicly like I always do. Turn notifications on. If you’re not following yet, you’ll understand why that was a mistake later.
0 · Reply
BloomBoom
BloomBoom Jul. 19 at 5:05 AM
1 · Reply
Achandler787
Achandler787 Jul. 18 at 8:36 PM
$CABA so to be clear $LLY has recently invested in $CABA and their Chief Science officer is personally advising the business: plus Lily is printing cash and wants to buy (And has bought recently) immunology companies for Billions! CABA is a penny stock with potentially a home run immune disease 🦠 curative platform. All momentum stocks had a 27 year record sell off last week: not financial advice : BUY LOW ——😝
1 · Reply
Higherself
Higherself Jul. 18 at 1:38 PM
$CABA So if a hanle is formed at roughly the $3 mark to finish the little cup then the run up to form the 2nd side of the big cup...some quick hypothetical math gets me to $4.40 from 1st cup $9.65 on tbe 2nd...again completely hypothetical as we can 't see handles yet. Or am I looking at what your seeing starting wrong?
1 · Reply
Higherself
Higherself Jul. 18 at 1:28 PM
$CABA Is this a possible double cup? It says a double cup forms if a stock falls to a suppor level & makes a small (W) shaped recovery before completing the large cup! Am i seeing things or is this exactly what's happening?
0 · Reply
WastedTrader
WastedTrader Jul. 18 at 4:28 AM
$CABA this is going to/forming a new massive cup, if you were here in the 1's you know what im talking about 🚀😎
0 · Reply
Achandler787
Achandler787 Jul. 18 at 4:16 AM
$CABA Nice! Great weekend- better week next week ✅😊
0 · Reply
Moonman321
Moonman321 Jul. 17 at 8:14 PM
$CABA 💪🏻 I feel sorry for the week hands that sold yesterday Great strength on a bloodbath day Like I’ve been saying for months, the rotation is gaining strength 
0 · Reply
Viktor4o
Viktor4o Jul. 17 at 8:02 PM
$CABA Abduuuul Abduuul where are you???
1 · Reply
Bronco6970
Bronco6970 Jul. 17 at 7:49 PM
$CABA BULLISH
0 · Reply
pleasemoney
pleasemoney Jul. 17 at 7:25 PM
$CABA lets remember how macro affected recent price of caba and other stocks with similiar risk profile. one of the most violent high-beta/momentum unwinds since 2008
1 · Reply
David_M_
David_M_ Jul. 17 at 4:11 PM
$CABA Up almost 3%!
0 · Reply
Achandler787
Achandler787 Jul. 17 at 11:53 AM
$CABA HUGE!
0 · Reply
MiroslavBroz
MiroslavBroz Jul. 17 at 5:01 AM
0 · Reply
Achandler787
Achandler787 Jul. 16 at 8:18 PM
$CABA hmmmm CABA
0 · Reply
Jarvis7424
Jarvis7424 Jul. 16 at 7:06 PM
$CABA added more. Averaged down big time today
0 · Reply
Jarvis7424
Jarvis7424 Jul. 16 at 6:07 PM
$CABA Longer-term PC-free RESET-PV and RESET-SLE data AND Higher-dose PC-free rese-cel data coming anytime between now and end of the year
0 · Reply
David_M_
David_M_ Jul. 16 at 5:22 PM
$CABA where bottom? where?
0 · Reply